Longitudinal one-year study of levels and stoichiometry of neurofilament heavy and light chain concentrations in CSF in patients with multiple system atrophy
Axel Petzold(University College London), Lars Rosengren(Sahlgrenska University Hospital), Geoffrey Keir(National Hospital for Neurology and Neurosurgery), Nil Dizdar(University of Cambridge), Olivier Rascol(Inserm), Gregor K. Wenning(Innsbruck Medical University), Eduardo Tolosa(Biomedical Research Networking Center on Neurodegenerative Diseases), Björn Holmberg(Sahlgrenska University Hospital), Edward J. Thompson(National Hospital for Neurology and Neurosurgery), Niall Quinn(University College Dublin)
Cited by 22
Related Papers
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
|New England Journal of Medicine|2009|889
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
|Movement Disorders|2017|846
Blood GFAP as an emerging biomarker in brain and spinal cord disorders
|Nature Reviews Neurology|2022|809
The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy
|Movement Disorders|2022|788